Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today

CRISPR Therapeutics CRSP has outperformed the market over the past 5 years by 2.15% on an annualized basis producing an average annual return of 15.64%. Currently, CRISPR Therapeutics has a market capitalization of $5.00 billion.

Buying $100 In CRSP: If an investor had bought $100 of CRSP stock 5 years ago, it would be worth $223.41 today based on a price of $62.90 for CRSP at the time of writing.

CRISPR Therapeutics's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.